Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Martiat

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Revue Medicale De Bruxelles|December 3, 2003
[Chronic myeloid leukemia in 2003]P Lewalle, P Martiat
Leukemia & Lymphoma|January 1, 1993
Inhibition of P210 expression in chronic myeloid leukaemia: oligonucleotides and/or transduced antisense sequencesP Lewalle, P Martiat
Leukemia & Lymphoma|January 1, 1993
Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?J L Michaux, P Martiat
Stem Cells (Dayton, Ohio)|October 1, 1993
Antisense inhibition of P210 bcr-abl in chronic myeloid leukemiaJ L Vaerman, P Lewalle, P Martiat
Blood|July 1, 1991
Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique HématologiqueP Martiat, J L Michaux, J Rodhain
Journal of Immunological Methods|June 16, 2000
Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuliP Lewalle, R Rouas, F Lehmann, et al.
Acta Clinica Belgica|January 1, 1989
Low-dose cytosine arabinoside in myelodysplastic syndromesP Mineur, P Martiat, A Ferrant, et al.
Hematological Oncology|October 1, 1988
Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndromeP Martiat, A Ferrant, J L Michaux, et al.
Acta Clinica Belgica|January 1, 1986
Low-dose cytosine arabinoside in myelodysplastic syndromesP Martiat, P Mineur, A Ferrant, et al.
Stem Cells and Development|September 3, 2005
Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral bloodC De Bruyn, A Delforge, P Martiat, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Revue Medicale De Bruxelles|December 3, 2003
[Chronic myeloid leukemia in 2003]P Lewalle, P Martiat
Leukemia & Lymphoma|January 1, 1993
Inhibition of P210 expression in chronic myeloid leukaemia: oligonucleotides and/or transduced antisense sequencesP Lewalle, P Martiat
Leukemia & Lymphoma|January 1, 1993
Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?J L Michaux, P Martiat
Stem Cells (Dayton, Ohio)|October 1, 1993
Antisense inhibition of P210 bcr-abl in chronic myeloid leukemiaJ L Vaerman, P Lewalle, P Martiat
Blood|July 1, 1991
Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Français de Cytogénétique HématologiqueP Martiat, J L Michaux, J Rodhain
Journal of Immunological Methods|June 16, 2000
Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuliP Lewalle, R Rouas, F Lehmann, et al.
Acta Clinica Belgica|January 1, 1989
Low-dose cytosine arabinoside in myelodysplastic syndromesP Mineur, P Martiat, A Ferrant, et al.
Hematological Oncology|October 1, 1988
Intensive chemotherapy for acute non-lymphoblastic leukemia after primary myelodysplastic syndromeP Martiat, A Ferrant, J L Michaux, et al.
Acta Clinica Belgica|January 1, 1986
Low-dose cytosine arabinoside in myelodysplastic syndromesP Martiat, P Mineur, A Ferrant, et al.
Stem Cells and Development|September 3, 2005
Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral bloodC De Bruyn, A Delforge, P Martiat, et al.
Pageof 8